Target intelligence / Profile preview

Survival gene messenger RNAs (DISE targets)

Target
DISE targets
Molecular classification
Messenger RNA, Survival genes
01

Overview

Non-E2F1 mRNAs with seed-region complementarity refers to a collective group of messenger RNAs (mRNAs) that are targeted by specific small RNAs to induce a potent form of cell death known as Death Induced by Survival gene Elimination (DISE) (Putzbach et al., 2017). This mechanism was discovered when researchers observed that siRNAs designed to knockdown the E2F1 transcription factor remained toxic even in cells lacking E2F1, due to their 6-nucleotide seed sequences binding to the 3' untranslated regions (UTRs) of numerous essential survival genes (Gao et al., 2018). By simultaneously downregulating multiple pathways required for cell viability, this approach bypasses the common resistance mechanisms cancer cells develop against single-target therapies (Peter et al., 2019). The target is essentially a functional network of survival-critical transcripts rather than a single protein or gene, and it is exploited by both experimental siRNAs and endogenous microRNAs like miR-34a and let-7 (Putzbach et al., 2017). While primarily an experimental concept, it informs the development of miRNA-based therapeutics and explains the off-target toxicity profiles of certain RNA interference (RNAi) drugs (Hadji et al., 2014).

Other names
Non-E2F1 mRNAs with seed-region complementarityDISE-sensitive mRNAs6mer seed targetsSurvival gene network
02

Mechanism of action

Induction of Death Induced by Survival gene Elimination (DISE) through RNA-induced silencing complex (RISC)-mediated degradation or translational inhibition of multiple essential survival genes (Putzbach et al., 2017).

03

Biological functions

Cell survivalApoptosis regulationGene expression regulationRNA interference (RNAi)
04

Disease associations

Cancer
05

Safety considerations

Off-target effects in healthy cells (Peter et al., 2019)Delivery challenges for RNA therapeuticsPotential for innate immune activation
06

Interacting drugs

siE2F1-702 (Experimental)

3 more in the full profile.

07

Biomarkers

Survival gene expression levels (Putzbach et al., 2017)3' UTR sequence composition and length (Gao et al., 2018)RISC-associated RNA sequencing (Gao et al., 2018)

Beyond the preview

Go deeper on Survival gene messenger RNAs (DISE targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Survival gene messenger RNAs (DISE targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call